- Corporate Officers - O
- Orbimed Capital Gp Vii Llc
Insider Trading History of Orbimed Capital Gp Vii Llc
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Orbimed Capital Gp Vii Llc since 2018.
This trader's CIK number is 1760648.
At the time of last reporting, Orbimed Capital Gp Vii Llc was the Officer of Passage Bio, Inc.. (stock ticker symbol PASG).
Also see all insider trading activities at Passage Bio, Inc..
Note that in the past
OrbiMed Capital GP VII LLC also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Theseus Pharmaceuticals, Inc. (THRX) by Orbimed Capital Gp Vii Llc
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | THRX | 479,932 | $1,463,792 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Synthorx, Inc. (THOR) by Orbimed Capital Gp Vii Llc
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | THOR | 1,363,636 | $14,999,996 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Enliven Therapeutics, Inc. (IMRA) by Orbimed Capital Gp Vii Llc
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | IMRA | 937,500 | $15,000,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Passage Bio, Inc. (PASG) by Orbimed Capital Gp Vii Llc
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | PASG | 0 | $0 | 1,338,526 | $571,195 | 0 | $0 |
| 2024 | PASG | 0 | $0 | 398,810 | $303,955 | 0 | $0 |
| 2023 | PASG | 1,192,577 | $1,001,763 | 0 | $0 | 0 | $0 |
| 2022 | PASG | 1,212,400 | $4,763,092 | 0 | $0 | 0 | $0 |
| 2020 | PASG | 373,300 | $6,719,400 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Arcutis Biotherapeutics, Inc. (ARQT) by Orbimed Capital Gp Vii Llc
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | ARQT | 0 | $0 | 1,220,171 | $25,451,009 | 0 | $0 |
| 2020 | ARQT | 1,054,888 | $21,901,096 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Third Harmonic Bio, Inc. (THRD) by Orbimed Capital Gp Vii Llc
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | THRD | 300,000 | $5,100,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Galecto, Inc. (GLTO) by Orbimed Capital Gp Vii Llc
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | GLTO | 0 | $0 | 681,948 | $1,681,548 | 0 | $0 |
Insider trading activities at 7 companies by Orbimed Capital Gp Vii Llc:
1. Theseus Pharmaceuticals, Inc. (THRX)
2. Synthorx, Inc. (THOR)
3. Enliven Therapeutics, Inc. (IMRA)
4. Passage Bio, Inc. (PASG)
5. Arcutis Biotherapeutics, Inc. (ARQT)
6. Third Harmonic Bio, Inc. (THRD)
7. Galecto, Inc. (GLTO)
Table 1. Insider trading of Theseus Pharmaceuticals, Inc. (THRX) by Orbimed Capital Gp Vii Llc
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-07-17 | THRX | Buy | 479,932 | 3.05 | 1,463,792 |
Table 2. Insider trading of Synthorx, Inc. (THOR) by Orbimed Capital Gp Vii Llc
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-12-11 | THOR | Buy | 1,363,636 | 11.00 | 14,999,996 |
Table 3. Insider trading of Enliven Therapeutics, Inc. (IMRA) by Orbimed Capital Gp Vii Llc
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-03-12 | IMRA | Buy | 937,500 | 16.00 | 15,000,000 |
Table 4. Insider trading of Passage Bio, Inc. (PASG) by Orbimed Capital Gp Vii Llc
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-06-25 | PASG | Sale | 138,800 | .33 | 45,804 |
| 2025-06-26 | PASG | Sale | 213,257 | .33 | 70,374 |
| 2025-06-24 | PASG | Sale | 231,600 | .35 | 81,060 |
| 2025-04-22 | PASG | Sale | 78,049 | .34 | 26,536 |
| 2025-04-23 | PASG | Sale | 89,328 | .34 | 30,371 |
| 2025-04-24 | PASG | Sale | 68,195 | .32 | 21,822 |
| 2025-04-17 | PASG | Sale | 77,090 | .33 | 25,439 |
| 2025-04-16 | PASG | Sale | 61,638 | .33 | 20,340 |
| 2025-04-15 | PASG | Sale | 10,326 | .38 | 3,923 |
| 2025-01-10 | PASG | Sale | 126,209 | .66 | 83,297 |
| 2025-01-13 | PASG | Sale | 17,986 | .64 | 11,511 |
| 2025-01-14 | PASG | Sale | 79,024 | .60 | 47,414 |
| 2025-01-08 | PASG | Sale | 75,007 | .68 | 51,004 |
| 2025-01-07 | PASG | Sale | 52,536 | .71 | 37,300 |
| 2025-01-06 | PASG | Sale | 19,481 | .77 | 15,000 |
| 2024-12-09 | PASG | Sale | 54,181 | .84 | 45,512 |
| 2024-12-10 | PASG | Sale | 8,015 | .80 | 6,412 |
| 2024-12-11 | PASG | Sale | 80 | .80 | 64 |
| 2024-12-06 | PASG | Sale | 20,903 | .82 | 17,140 |
| 2024-12-04 | PASG | Sale | 76,200 | .79 | 60,198 |
| 2024-09-19 | PASG | Sale | 39,300 | .71 | 27,903 |
| 2024-09-18 | PASG | Sale | 25,631 | .73 | 18,710 |
| 2024-09-17 | PASG | Sale | 111,400 | .73 | 81,322 |
| 2024-09-16 | PASG | Sale | 63,100 | .74 | 46,694 |
| 2023-06-27 | PASG | Buy | 617,382 | .84 | 518,600 |
| 2023-06-28 | PASG | Buy | 575,195 | .84 | 483,163 |
| 2022-05-03 | PASG | Buy | 221,500 | 1.93 | 427,495 |
| 2022-05-04 | PASG | Buy | 303,500 | 1.94 | 588,790 |
| 2022-01-20 | PASG | Buy | 369,100 | 5.42 | 2,000,522 |
| 2022-01-14 | PASG | Buy | 10,300 | 5.60 | 57,679 |
| 2022-01-18 | PASG | Buy | 114,700 | 5.46 | 626,262 |
| 2022-01-19 | PASG | Buy | 43,300 | 5.11 | 221,263 |
| 2022-01-13 | PASG | Buy | 41,800 | 5.52 | 230,735 |
| 2022-01-12 | PASG | Buy | 100,000 | 5.65 | 565,000 |
| 2022-01-11 | PASG | Buy | 8,200 | 5.53 | 45,346 |
| 2020-02-28 | PASG | Buy | 373,300 | 18.00 | 6,719,400 |
Table 5. Insider trading of Arcutis Biotherapeutics, Inc. (ARQT) by Orbimed Capital Gp Vii Llc
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-06-24 | ARQT | Sale | 341,971 | 21.31 | 7,287,402 |
| 2022-04-08 | ARQT | Sale | 200,000 | 20.71 | 4,142,000 |
| 2022-04-07 | ARQT | Sale | 344,996 | 20.66 | 7,127,617 |
| 2022-04-06 | ARQT | Sale | 333,204 | 20.69 | 6,893,990 |
| 2020-10-02 | ARQT | Buy | 496,000 | 25.00 | 12,400,000 |
| 2020-02-03 | ARQT | Buy | 558,888 | 17.00 | 9,501,096 |
Table 6. Insider trading of Third Harmonic Bio, Inc. (THRD) by Orbimed Capital Gp Vii Llc
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-09-19 | THRD | Buy | 300,000 | 17.00 | 5,100,000 |
Table 7. Insider trading of Galecto, Inc. (GLTO) by Orbimed Capital Gp Vii Llc
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-07-31 | GLTO | Sale | 209,400 | 3.00 | 628,200 |
| 2023-07-25 | GLTO | Sale | 39,200 | 2.92 | 114,464 |
| 2023-07-13 | GLTO | Sale | 194,700 | 2.40 | 467,280 |
| 2023-04-13 | GLTO | Sale | 13,946 | 1.82 | 25,381 |
| 2023-04-14 | GLTO | Sale | 41,446 | 1.86 | 77,089 |
| 2023-04-17 | GLTO | Sale | 13,089 | 1.97 | 25,785 |
| 2023-04-10 | GLTO | Sale | 51,228 | 1.79 | 91,698 |
| 2023-04-11 | GLTO | Sale | 13,946 | 1.82 | 25,381 |
| 2023-04-12 | GLTO | Sale | 2,363 | 1.81 | 4,277 |
| 2023-04-06 | GLTO | Sale | 9,665 | 2.00 | 19,330 |
| 2023-04-05 | GLTO | Sale | 92,965 | 2.18 | 202,663 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Orbimed Capital Gp Vii Llc
(Officer of Passage Bio, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.